Oxidative brain and cerebellum injury in diabetes and prostate cancer model: Protective effect of metformin
Journal of Biochemical and Molecular Toxicology · 2023
DOI: 10.1002/jbt.23440 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2023. Verfasst von Eda Dagsuyu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Faculty of Engineering, Istanbul University-Cerrahpaşa, Istanbul, Turkey. Hauptthemen laut MEDLINE: Metformin, Diabetes Mellitus, Experimental, Prostatic Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 71 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
The body can host the spread of prostate cancer cells. Metastases from prostate cancer are more frequently seen in the brain, liver, lungs, and lymph nodes. A well‐known antidiabetic drug, metformin, is also known to have antitumor effects. Our study focuses on the evaluation of potential metformin protective effects on brain and cerebellum damage in streptozotocin (STZ)‐induced diabetic and Dunning prostate cancer models. In this investigation, six groups of male Copenhagen rats were created: control, diabetic (D), cancer (C), diabetic + cancer (DC), cancer + metformin, and diabetic + cancer + metformin. The brain and cerebellum tissues of the rats were taken after sacrifice. Oxidative stress markers including reduced glutathione level, lipid peroxidation, glutathione reductase, glutathione peroxidase, glutathione‐ S ‐transferase, catalase, superoxide dismutase activities, reactive oxygen species, total oxidant and total antioxidant status, lactate dehydrogenase, xanthine oxidase, acetylcholinesterase activities, protein carbonyl contents, nitric oxide and OH‐proline levels, sodium potassium ATPase, carbonic anhydrase, and glucose‐6‐phosphate dehydrogenase activities; glycoprotein levels including hexose, hexosamine, fucose, and sialic acid levels; and histone deacetylase activity as a cancer marker were determined. Oxidative stress markers were impaired and glycoprotein levels and histone deacetylase activity were increased in the D, C, and DC groups. Metformin therapy reversed these effects. Metformin was found to protect the brain and cerebellum of STZ‐induced diabetic rats with Dunning prostate cancer from harm caused by MAT‐Lylu metastatic cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Faculty of Engineering, Istanbul University-Cerrahpaşa, Istanbul, Turkey.
- Department of Histology and Embryology, Faculty of Medicine, Halic University, Istanbul, Turkey.
- Department of Biology, Faculty of Science, Istanbul University, Istanbul, Turkey.
Zitieren
APA
Dagsuyu, E., Koroglu, P., Gul, I. B., Bulan, O. K., & Yanardag, R. (2023). Oxidative brain and cerebellum injury in diabetes and prostate cancer model: Protective effect of metformin. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.23440
Vancouver
Dagsuyu E, Koroglu P, Gul IB, Bulan OK, Yanardag R. Oxidative brain and cerebellum injury in diabetes and prostate cancer model: Protective effect of metformin. Journal of Biochemical and Molecular Toxicology. 2023. doi:10.1002/jbt.23440
BibTeX
@article{Dagsuyu2023,
author = {Dagsuyu, Eda and Koroglu, Pınar and Gul, Ilknur B and Bulan, Omur K and Yanardag, Refiye},
title = {Oxidative brain and cerebellum injury in diabetes and prostate cancer model: Protective effect of metformin},
journal = {Journal of Biochemical and Molecular Toxicology},
year = {2023},
doi = {10.1002/jbt.23440}
}
EUVIMED